It was reported that a patient presented with grade 4 degenerative mitral regurgitation (mr) and posterior leaflet segment 1 (p1) flail for a mitraclip procedure.There were no imaging challenges.The first clip was implanted successfully.The second clip (31026a2017) had some difficulty with grasping, but a grasp was achieved.The clip was perpendicular to line of coaptation and leaflet insertion assessment was satisfactory.The lock line was removed and it was noted that mr had worsened.A loss of leaflet capture occurred and the clip took off a chunk of the anterior leaflet.The posterior leaflet was still attached.The lock line was already removed, so the clip was deployed on the one leaflet.To further reduce the mr a third and fourth clip were implanted, with the intent of stabilizing the second clip.All other clips were implanted successfully, with exception of the xt clip.The xt was attempted to be steered in-between the second clip and third (xt).The movements/ maneuverability of the delivery catheter shaft was not as intended.There was an attempt to re-key the device, but it continued to be irregular.Per the physician the dc shaft was moving in the intended direction, but it did not feel normal.They were attempting to gain height above the valve, and during advancement the dc shaft was not moving as intended.The xt was removed and a replacement was implanted successfully (which was the 4th clip).The patient was stable and there was no clinically significant delay.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot-specific quality issue.Based on available information, the cause of the reported difficult grasping/capturing and tissue injury were unable to be determined.The reported patient effect of tissue injury, as listed in the mitraclip system instructions for use, is a known possible complication associated with mitraclip procedures.The reported unexpected medical intervention was a result of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|